In this case, the serially enriched brain-competent isogenic CTCs may reflect selection pressure for pre-existing cells with elevated hypoxic signaling, although we cannot exclude additional induction of HIF1A activity during the process of brain tumor initiation. The gene discussed is HIF1A; the disease is brain neoplasm.